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PACT/Hazardexpert. However, by the rule
they claim to have used (equivocal carcino-
gens are regarded as noncarcinogens), onlyy-
butyrolactone is predicted correctly.
Inclusion ofadditional related vari-
ables in thepredictive method. After the
carcinogenicity outcomes were known,
Lewis et al. found that the predictive per-
formance of COMPACT could be
enhanced if they included an additional
COMPACT prediction (C2E) and also a
predictor variable ("Hazardexpert") that
incorporates information about metabo-
lism. While there is nothing inherently
wrong with including additional variables
in a predictive methodology, this exercise
should ideally have been carried out
prospectively, not retrospectively. It is
much easier to find predictive variables
that work once the study outcomes to be
predicted are known. The important (and
yet to be answered) question is, how will
the authors' newly derived, multivariate
predictive methodology fare for prospec-
tive predictions? Hopefully, it will be bet-
ter than COMPACT's limited predictive
success (56%) for the 44 NTP chemicals.
The combination of COMPACT and
Hazardexpert eliminated the apparent dis-
cordance for three chemicals: tris(2-
chloroethyl)phosphate, 2,3-dibromo-1-
propanol, and 1,2,3-trichloropropane,
while introducing discordance for another
chemical previously predicted correctly
(methyl bromide). However, the authors
misclassify two other chemicals: chlo-
ramine and HC Yellow 4, both of which
are reported as successful predictions, but
in fact were not predicted correctly (see
Table 2). Including additional predictor
variables (and not correcting for the mis-
classification of chloramine and HC
Yellow 4) reduced the number of discor-
dant predictions from 11 to 8.
Inclusion ofadditional, apparently
unrelated, variables in the predictive
method. The eight chemicals that Lewis et
al. conclude are not correctly predicted by
COMPACT/Hazardexpert are designated
in their Table 4 (p. 182). The authors then
carry out further analyses to reduce the
number of discordant predictions from
eight to five. Frankly, it is unclear exactly
how the authors achieve this reduction. It
appears that the basis for eliminating the
final three chemicals from "discordancy"
was an appeal to "structural alert, chronic
toxicity studies, and the Ames test," which
correctly predicted the carcinogenicity of
o-benzyl-p-chlorophenol, methylphenidate
hydrochloride, and diphenylhydantoin,
three chemicals "missed" by COM-
PACT/Hazardexpert. One other chemical
(mercuric chloride) not even evaluated by
COMPACT/Hazardexpert, but correctly
identified by "the metal ion redox poten-
tials for inorganic compounds," was also
apparently added in as a correct prediction.
The authors should justify how these addi-
tional predictions, based on apparently
unrelated variables, can be meaningfully
interpreted as improving the performance
ofCOMPACT/ Hazardexpert. In any case,
the authors include these successful predic-
tions in their calculations and conclude
that the concordance for COMPACT/
Hazardexpert when predicting rodent car-
cinogenicity is 86% (32/37). I leave it to
the reader's judgment to determine how
much confidence to place in this figure.
I have no objection to the development
of techniques designed to predict rodent
(or more importantly, human) carcino-
genicity, and I suspect that it is possible to
develop methods that will be successful in
this regard. However, I strongly urge cau-
tion in placing too much confidence in
COMPACT or in any other predictive
method that has little success when applied
prospectively and seems to work onlywhen
applied retrospectively to the original data
set, using extensive (and scientifically ques-
tionable) data manipulations and reanalysis.
Joseph K. Haseman
National Institute ofEnvironmental
Health Sciences
Research Triangle Park, North Carolina
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Response
In response to Joe Haseman's letter, we
would like to point out that although our
article is retrospective with regard to the
rodent carcinogenicity study of the 40
chemicals, the COMPACT data were avail-
able at the time of the release of the car-
cinogenicity assays. The Hazardexpert eval-
uations for the 40 chemicals were carried
out after the NIEHS conference, but the
Hazardexpert system (available commer-
cially from Compudrug Ltd) is not part of
COMPACT. The following account, hope-
fully, provides some clarification of the
points raised in Dr. Haseman's letter.
Most other systems publish their pre-
dictions or analyses without providing any
mathematical derivation which can be
reproduced by others. In contrast, we show
how our predictions/analyses are generated
from numerical values (COMPACT para-
meters) for molecular and electronic fea-
tures of each chemical. Our attempts to
provide a numerical description of the
COMPACT plot of molecular planarity/
potential chemical reactivity, have not
been entirely successful, due to the fact
that the training set of chemicals shows a
curved line discriminating P4501 specifici-
ty from other P450 isozymes, whereas the
COMPACT ratio (either area/depth2/AE
or area/depth2/AE - 8) gives a straight line
relationship. This results in some chemi-
cals (e.g., resorcinol) having a COMPACT
ratio and a COMPACT graphical plot
which give conflicting results, but the
graph is the original paradigm. We have
recently derived an expression which is
more complex (1), based on analysis ofthe
COMPACT curve, and this gives more
precise results in terms of correlation with
the graph, although the actual graphical
representation is preferred.
Resorcinol was predicted to be positive
in COMPACT using the COMPACT
ratio, but the graph of area/depth2 versus
AE as presented at the 1993 NTP confer-
ence (2) clearly shows that this compound
should be negative as it is outside the
curve. This is the only example in all ofthe
40 chemicals of a discrepancy between the
approximation of the COMPACT ratio
and the accurate description of the graph.
As the EHP paper is retrospective, we feel
justified in making this point, even though
the graphical description was available in
the conference documentation. HC Yellow
4 was changed from positive in COM-
PACT to negative, due to the fact that the
original structure sent to us by NTP was
erroneous and was subsequently changed
by NTP after our original predictions had
been published. When we ran the new
(correct) structure through our system, it
proved negative, and we feel justified in
making this clear in our retrospective study
published in EHP. However, we provided
revised data (including the aforementioned
cases) and distributed this at the NTP con-
ference, which, moreover, included our
results for the P4502E descriptor, now
provided in the February 1995 issue of
EHP(103:178-184).
The Hazardexpert analyses were gener-
ated retrospectively as we had only recently
purchased the software. As can be seen
from our EHP paper, the Hazardexpert
results (which utilize the EPA database)
give quite good concordances with positive
carcinogens, and they are better than the
Ames test for negatives and also overall.
Regarding the relatively poor perfor-
mance of the original computer-based pre-
dictions compared with that of Ashby,
Tennant, and others, it should be empha-
sized that the latter employed a combina-
tion of mutagenicity, subchronic toxicity,
and structural alert tests, which are, there-
fore, three evaluations combined into one
prediction-so it is perhaps not surprising
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that this combination of three different
tests gives the best overall concordance with
rodent carcinogenicity. It is well known
that theAmes test gives onlyjust over 50%
concordance with rodent carcinogenicity,
but it is still extensively used. This is
because it has a well-defined endpoint that
one can readily understand in biological
terms, i.e., genotoxicity. However, there is
overwhelming evidence to show that
enzymes of the cytochrome P450 super-
family are involved in the metabolism and
toxicity of most (-90%) chemicals. P450s
play a pivotal role in toxicity and carcino-
genicity, and the COMPACT system is
designed to identify P450-mediated metab-
olism and metabolic activation. Although
this system (3) was originally based solely
on the structures of known P450 sub-
strates, we have now generated full three-
dimensional structures (4) of the mam-
malian enzymes themselves (including
human isoforms) which agree closely with
experimental findings. However, we are
also aware that there are other mechanisms
ofcarcinogenicity that do not require P450
activation, and structure alert systems can
be useful in identifying direct-acting car-
cinogens, forexample (1,5).
Nongenotoxic carcinogens are not so
easy to predict butwe are elaborating mod-
els to identify chemicals involved in perox-
isome proliferation and other activation
pathways such as 9-lyase cleavage. Even-
tually there will be a battery of tests in
place, which we hopewill adequately assess
the likely risk to manfrom exposure to for-
eign compounds; so models of human
enzymes and receptors which may mediate
potentially carcinogenic events will be
important. What is crucial is the determi-
nation ofhow readily a chemical is metab-
olized and whether any reactive intermedi-
ates (ROS or metabolites) are sufficiently
long-lived to cause irreparable DNA dam-
age. There maywell be short-term test pro-
cedures developed which can assess these
factors in vitro, but computer-based sys-
tems can be just as accurately predictive;
however, these computer systems do not
require synthesis of the chemical, are
extremely rapid, and, consequently, rela-
tively inexpensive. We appreciate that tra-
ditional toxicologists may have been suspi-
cious of replacing biological tests with
computer predictions, but there is evidence
that attitudes are changing.
One reason for publishing our retro-
spective study of the 40 NTP chemicals
was to show that it is possible for a combi-
nation of tests to give reasonable concor-
dances with rodent carcinogenicity, and we
did not anticipate that moderating the
equivocal results ofthe rodent study in the
light of the pathology report presented at
the NTP conference would be controver-
sial. Our EHP paper was independently
refereed and, as our use ofmodified equiv-
ocal results (reported at the meeting) was
not questioned by the referees, one can
only presume that NIEHS (which publish-
es EHP and also organized the 1993 con-
ference) did not find this contentious. The
problem regarding equivocals is well
known, and these are obviously difficult to
assess by predictive systems which, in gen-
eral, do not equivocate. In fact, some sys-
tems (e.g., TOPKAT, CASE) tend to
exclude equivocal results in the rodent
assay when they validate their methods. At
the NIEHS conference in 1993 there was
lengthy discussion about equivocals, and
the prevailing doctrine from NTP was to
regard these as negatives, although there
was not universal agreement for this view
among the delegates. During the presenta-
tion ofthe pathology results it was indicat-
ed that a few of the equivocals could be
interpreted, on histopathological evidence,
as being weakly positive. It did not seem
unreasonable to us in our retrospective
analysis to take into account the views of
the NIEHS pathologist who conducted the
examinations. However, if one excludes
the equivocals, the concordance between
COMPACT and the rodent assay becomes
70% (21/30), which is not much different
from the concordance one gets from
regarding three of the equivocals as posi-
tives. Ifone regards all ofthe equivocals as
positives, the concordance between COM-
PACT and the rodent carcinogenicity is
69% (25/36), whereas taking them as neg-
ative lowers the concordance further to
64% (23/36). However, it should be noted
that if these three equivocals are regarded
as positive, most (if not all) ofthe predic-
tive tests show a similar improvement.
The use of metal ion redox potentials
for providing some estimate of carcino-
genicity is not currently part of COM-
PACT, but it is of interest to show that
physicochemical parameters may be
employed to try to predict the potential
carcinogenicity of inorganic compounds.
Likewise, Hazardexpert is not part of
COMPACT, but the two tests are fairly
complementary in the comparisons we
have made to date (1,6).
In our EHPpaper we provide explana-
tions of the results for each chemical,
including possible reasons why some of
these were discordant with the rodent
assay. However, we have not altered our
results in the light of this additional bio-
chemical knowledge, especially when the
predictive methods (e.g., Ames test, Ashby
structural alert, etc.) were able to predict
correctly the outcome of the rodent car-
cinogenicity study for those chemicals. The
purpose of these developments of predic-
tive systems is to be able to decrease the
number of animal experiments and the
time required for the safety evaluation of
chemicals that are destined for human
exposure, and we believe that a combina-
tion of several systems represents the best
way to achieve this (6), with the considera-
tion ofP450-mediated pathways ofactiva-
tion and detoxication being most impor-
tant. Our EHP paper merely attempts to
show how a combination ofsystems might
work, but wewould appreciate advice from
a statistician on how to "weight" such tests:
perhapsJoe Haseman could help us.
D. F. V. Lewis
C. Ioannides
D. V. Parke
University ofSurrey
Guildford, Surrey, UK
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Drinking Water and Leukemia
Cohn et al. recently expanded (EHP
102:556-561) on an earlier ecological
study (1) of leukemia and drinking water
in northern New Jersey. The initial study
suggested an association between volatile
organic hydrocarbon (VOC) contamina-
tion ofdrinking water and increased risk of
leukemia among females (but not males).
The authors concluded that 1) the appear-
ance of an association for females only
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